TipRanks
Advertisement
Advertisement

DE:A7L Stock Latest News

CRISM Therapeutics Sets AGM Date as Phase 2 Glioblastoma Trial Recruitment Begins
Company AnnouncementsCRISM Therapeutics Sets AGM Date as Phase 2 Glioblastoma Trial Recruitment Begins
7d ago
CRISM Therapeutics advances Phase 2 glioblastoma trial and strengthens funding for ChemoSeed platform
PremiumCompany Announcements
CRISM Therapeutics advances Phase 2 glioblastoma trial and strengthens funding for ChemoSeed platform
18d ago
CRISM Therapeutics names seasoned healthcare dealmaker as chair amid Phase 2 trial push
PremiumCompany Announcements
CRISM Therapeutics names seasoned healthcare dealmaker as chair amid Phase 2 trial push
22d ago
CRISM Therapeutics Starts Phase II ChemoSeed Trial in Glioblastoma
PremiumCompany Announcements
CRISM Therapeutics Starts Phase II ChemoSeed Trial in Glioblastoma
2M ago
CRISM Therapeutics Clears Key Step to Begin Phase II Glioblastoma Trial
PremiumCompany Announcements
CRISM Therapeutics Clears Key Step to Begin Phase II Glioblastoma Trial
2M ago
CRISM Therapeutics Reveals Concentrated Shareholder Base After Register Analysis
PremiumCompany AnnouncementsCRISM Therapeutics Reveals Concentrated Shareholder Base After Register Analysis
2M ago
CRISM Therapeutics awards long-term share options to executive directors
Premium
Company Announcements
CRISM Therapeutics awards long-term share options to executive directors
3M ago
CRISM secures key approvals and funding as ChemoSeed platform advances toward Phase 2
Premium
Company Announcements
CRISM secures key approvals and funding as ChemoSeed platform advances toward Phase 2
4M ago
CRISM advances Phase 2 ChemoSeed trial for glioblastoma
PremiumCompany Announcements
CRISM advances Phase 2 ChemoSeed trial for glioblastoma
4M ago
CRISM Therapeutics Wins Shareholder Backing and Expands Capital Base After Funding Round
PremiumCompany Announcements
CRISM Therapeutics Wins Shareholder Backing and Expands Capital Base After Funding Round
4M ago
CRISM wins major UK grant to advance Phase 2 glioblastoma trial
PremiumCompany Announcements
CRISM wins major UK grant to advance Phase 2 glioblastoma trial
4M ago
CRISM wins Invest NI grant to advance prostate cancer ChemoSeed programme
PremiumCompany Announcements
CRISM wins Invest NI grant to advance prostate cancer ChemoSeed programme
4M ago
CRISM Therapeutics Upsizes Oversubscribed Retail Offer to Fund Cancer Drug Delivery Trials
PremiumCompany AnnouncementsCRISM Therapeutics Upsizes Oversubscribed Retail Offer to Fund Cancer Drug Delivery Trials
4M ago
CRISM Therapeutics Sets June General Meeting Following Fundraising
Premium
Company Announcements
CRISM Therapeutics Sets June General Meeting Following Fundraising
5M ago
CRISM Therapeutics launches retail offer to fund oncology pipeline
Premium
Company Announcements
CRISM Therapeutics launches retail offer to fund oncology pipeline
5M ago
CRISM Therapeutics Raises £2.5m to Advance ChemoSeed Cancer Trials
PremiumCompany Announcements
CRISM Therapeutics Raises £2.5m to Advance ChemoSeed Cancer Trials
5M ago
CRISM Therapeutics Reports Strong Preclinical Prostate Cancer Data for Docetaxel-ChemoSeed
PremiumCompany Announcements
CRISM Therapeutics Reports Strong Preclinical Prostate Cancer Data for Docetaxel-ChemoSeed
6M ago
CRISM Therapeutics reshapes board leadership as it advances toward phase 2 trial
PremiumCompany Announcements
CRISM Therapeutics reshapes board leadership as it advances toward phase 2 trial
6M ago
CRISM Therapeutics Pushes Phase 2 Glioblastoma Trial Start to H1 2026 After First ChemoSeed Batch Produced
PremiumCompany Announcements
CRISM Therapeutics Pushes Phase 2 Glioblastoma Trial Start to H1 2026 After First ChemoSeed Batch Produced
7M ago
CRISM Wins FDA Orphan Drug Status for Glioma ChemoSeed Programme
PremiumCompany AnnouncementsCRISM Wins FDA Orphan Drug Status for Glioma ChemoSeed Programme
7M ago
CRISM Therapeutics Wins Key Japanese Patent for ChemoSeed Cancer Implant
Premium
Company Announcements
CRISM Therapeutics Wins Key Japanese Patent for ChemoSeed Cancer Implant
9M ago
CRISM Therapeutics Reveals Updated Major Shareholders After December Fundraising
Premium
Company Announcements
CRISM Therapeutics Reveals Updated Major Shareholders After December Fundraising
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >